Near Zero: My peers and I met with journalists in Washington to discuss impact on biomedical R&D investment of redefining word “negotiation” to mean “dictating price”. Please hear us @SenatorMenendez @RonWyden @NPLB_org https://t.co/4ABgMzk4Ut
Patient cost-sharing for drugs in Medicare causes 33% increases in mortality because high-risk patients fail to fill prescriptions for life-saving drugs for a range of diseases, from @amitabhchandra2, @flack_evan, and @oziadias https://t.co/SaeCY75Zmw
Patients are our purpose. Science is our passion. Today, we stand united with biopharma colleagues around the world and reaffirm our long-standing commitment to ensuring that safety and rigorous science are our priorities in vaccine development. #InventingForLife
Thank you @USAIC for the opportunity to facilitate a discussion with India’s DCGI Dr. Somani, and Dr. Bhandari, Joint Sec, MoH - focus on driving regulatory reforms to support timely access to medicines
As high-value therapies for #COVID19 are developed, #LowValueCare continues to burden our health system. Check out the #GoingBelowTheSurface Forum’s new Roadmap for Addressing Low-Value Care that aims to tackle wasteful spending and prioritize high-value care.
The challenge of AMR is multifaceted and we must keep working to stay a step ahead. Learn why we’ve committed to investing $100 million over 10 years in the new @AMRActionFund with our industry partners to bring forward new treatment options for patients: https://t.co/FMgRX1yuTx
A great example indeed of how enabling pharmaceutical innovation pays off in perpetuity. @Merck and its scientific excellence in steroid chemistry in the 1950s, making an important difference in the fight against COVID-19 pandemic today
Now more than ever, our commitment to corporate responsibility and transparency is imperative. We're proud to be recognized as No.1 in our industry on the 2020 #100BestCC list: https://t.co/PFNVAko3G8 #ESG
I am extremely grateful to MSD, GSK, Innovax, Serum Institute of India and Walvax for committing to provide enough HPV vaccines to immunize at least 84 million girls in @Gavi-supported countries: https://t.co/1kmtsiWUmm
The pharmaceutical industry will be at the forefront of lighting the way out of this pandemic. So proud of Merck’s unwavering commitment to public health.
“There’s no way I can step away from this now. I can’t leave them at this stage. These are my patients as well.” Merck employee, Dr. Mo Ali, volunteers his time to treat #COVID19 patients. Learn more: https://t.co/zNowPKxv7r
“As we come together to fight today's #COVID19 crisis, we must also look ahead and put measures in place now to ensure that we have the antibiotics we need — today and in the future.” Read more from Dr. Julie Gerberding in @statnews. https://t.co/MwvDIYLkoG
Congress has an opportunity to lower drugs costs and advance American innovation to fight health challenges like #COVIDー19. We agree on so much, let’s get it done by May 22.
My op-ed in @WSJ https://t.co/x5L9UcBY9z